logo

For the Inventor, By the Inventor

Schopfheim, Germany

Bernd Buettelmann

USPTO Granted Patents = 58 

 

 

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 131(Granted Patents)

Forward Citations (Not Self Cited) = 109(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Palo Alto, CA (US) (2010 - 2012)
  • Schopfheim, DE (2002 - 2017)
  • Basel, CH (2019 - 2021)

Company Filing History:

goldMedal52 out of 4,945 
 
Hoffmann-la Roche Inc.
 patents
silverMedal7 out of 322 
 
Roche Palo Alto LLC
 patents
where one patent can have more than one assignee

Years Active: 2002-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Isoxazolyl Ether Derivatives
GABAα5 PAM
Spiroindolinones
DDR1 Inhibitors
Fatty-Acid Binding Protein Inhibitors
JNK Modulators
Imidazole Derivatives
Aryl-Isoxazole Derivatives
Pyridine Derivatives
Thiazole-4-Carboxyamide Derivatives
Dihydroquinone Inhibitors
Substituted Isoxazoles
58 patents (USPTO):Explore Patents
1. 11091471 - Isoxazolyl ether derivatives as GABAα5 PAM (2021-08-17),
2. 10618897 - Spiroindolinones as DDR1 inhibitors (2020-04-14),
3. 10435407 - Triaza-spirodecanones as DDR1 inhibitors (2019-10-08),
4. 10239876 - Triaza-spirodecanones as DDR1 inhibitors (2019-03-26),
5. 9708340 - Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors (2017-07-18),
6. 9656971 - COMT inhibitors (2017-05-23),
7. 9604977 - Bicyclic thiophenylamide compounds (2017-03-28),
8. 9562052 - Bicyclicpyridine derivatives (2017-02-07),
9. 9353102 - Non-annulated thiophenylamides (2016-05-31),
10. 9278918 - Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors (2016-03-08),
11. 9073908 - Isoxazolo-pyridine derivatives (2015-07-07),
12. 8877783 - Isoxazolo-pyridine derivatives (2014-11-04),
13. 8877782 - Isoxazolo-pyridine derivatives (2014-11-04),
14. 8846719 - Isoxazolo-pyridine derivatives (2014-09-30),
15. 8569306 - JNK modulators (2013-10-29),

Title: Innovations and Contributions of Bernd Buettelmann

Introduction: Bernd Buettelmann, an accomplished inventor based in Schopfheim, Germany, has made significant contributions to the field of medicinal chemistry and pharmacology. With an impressive portfolio of 58 patents, his work has played a crucial role in the development of new therapeutic compounds.

Latest Patents: One of Buettelmann's recent patents includes the discovery of Isoxazolyl ether derivatives as GABAα5 Positive Allosteric Modulators. This invention consists of compounds having a specific formula, where R, R, R, R, R, R, X, Y, and Z are defined within the patent description, along with compositions and methods of utilizing these compounds for therapeutic applications. Another notable patent is related to Spiroindolinones as DDR1 inhibitors. This invention involves specific compounds aimed at inhibiting DDR1, outlined in the patent's formula.

Career Highlights: Bernd Buettelmann has had a notable career with valuable experience at renowned pharmaceutical companies. He has worked with Hoffmann-La Roche Inc. and Roche Palo Alto LLC, where he has collaborated on various innovative projects that have contributed to advancements in medicine.

Collaborations: Throughout his career, Buettelmann has worked alongside talented professionals, including Andrew William Thomas and Henner Knust. These collaborations have fostered a dynamic research environment, leading to groundbreaking inventions and innovations in the pharmaceutical field.

Conclusion: Bernd Buettelmann's contributions to the field of pharmaceuticals through his numerous patents showcase his dedication to innovation and invention. His work continues to influence the development of new therapeutic compounds, making significant strides in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…